Aricept Approved In Japan As Treatment For Dementia With Lewy Bodies
Tokyo, Sept 19, 2014 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that its anti-Alzheimer's agent Aricept (donepezil hydrochloride) has received approval for a new indication for dementia with Lewy bodies (DLB) in Japan. DLB is considered to be one of Japan's three major types of dementia, alongside Alzheimer's disease and vascular dementia.
LeMaitre Vascular Acquires Angioscope
BURLINGTON, Mass. -- LeMaitre Vascular, Inc. , a provider of peripheral vascular devices and implants, announced today that on September 17, 2014 it acquired the angioscope product line from Applied Medical, ...
Researchers define spontaneous retinal neovascular mouse model
Researchers have characterized a novel mutant mouse model, termed neoretinal vascularization 2, which develops abnormal neovessels from retinal vascular plexus. Their hope is this new model will help them understand AMD and develop new treatments for the disease.
A glass of milk daily is good for your heart
The link between milk and risk for hyper-tension and cardio-vascular disease (CVD) was examined in a study recently presented at the 12th Euro Fed Lipid Congress in Montpellier, France.
Midtown Dentistry Warns Patients Not to Ignore Bleeding Gums
Midtown Dentistry in Houston, Texas, is currently trying to raise patients’ awareness of the connections between gum disease and general health. Numerous clinical studies have shown gum health can affect your general health, and vice versa, so it is vitally important not to miss regular checkups. (PRWeb August 24, 2014) Read the full story at http://www.prweb.com/releases/2014/08/prweb12113885 ...
Covidien Acquires Reverse Medical, Shares Decline
The acquisition of Reverse Medical is expected to complement Covidien plc's (COV) existing portfolio of vascular technologies, lending it a competitive edge in the worldwide vascular embolization market....